Skip to content
Screener

Orthofix Medical Inc. OFIX Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$203.1MBeat by $2.0M
EPS$0.13Beat by $0.09
Revenue estimate$201.1M
EPS estimate$0.04

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$210.7M
EPS estimate$0.11

Financials

Q2 2025

Income statement

See full
Revenue$203.1M+2.3%
Gross profit$139.5M+3.6%
Operating income-$16.0M+35.7%
Net income-$14.1M+57.9%
EPS (diluted)-$0.36+59.1%

Balance sheet

See full
Cash & equivalents$65.6M+149%
Total debt$178.3M+26.8%
Total equity$458.3M-16.1%
Total assets$837.2M-5.1%

Cash flow

See full
Operating cash flow$11.6M+29.6%
CapEx$7.1M-26.8%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$429.81M+87.6%
Enterprise value$542.55M+58.0%
P/S0.5×+0.2×

Profitability

See full
Gross margin67.4%+0.2pp
Operating margin-11.8%-0.7pp
Net margin-15.3%-0.3pp

Returns & leverage

See full
Return on equity-24.6%+6.6pp
Debt / equity0.4×+0.1×
Current ratio2.7×+0.2×

Segments

By segment

See full
Global Spine$169.8M+1.1%

FAQ

When did Orthofix Medical Inc. report Q2 2025 earnings?
Orthofix Medical Inc. (OFIX) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Orthofix Medical Inc.'s Q2 2025 revenue and EPS?
Orthofix Medical Inc. reported revenue of $203.1M and eps of $0.13 for Q2 2025.
Did Orthofix Medical Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $201.1M by $2.0M. EPS beat the consensus estimate of $0.04 by $0.09.
How did Orthofix Medical Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.3% from $198.6M a year earlier and eps grew 160.0% from $0.05.
Where can I find Orthofix Medical Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-102383) and the 10-Q periodic report (0000950170-25-102384) directly on SEC EDGAR. The filing index links above go to sec.gov.